Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from Mexico

被引:34
|
作者
Arredondo, Armando [1 ]
Reyes, Gabriela [1 ]
机构
[1] Natl Inst Publ Hlth, Res Ctr Hlth Syst, Cuernavaca, Morelos, Mexico
来源
PLOS ONE | 2013年 / 8卷 / 07期
关键词
COST; COMPLICATIONS;
D O I
10.1371/journal.pone.0068443
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in Mexico. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010-2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security-IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users' pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Trends and challenges in diabetes for middle-income countries: Evidence from Mexico
    Arredondo, Armando
    Orozco, Emanuel
    Beatriz Duarte, Maria
    Cuadra, Magali
    Lucia Recaman, Ana
    Azar, Alejandra
    [J]. GLOBAL PUBLIC HEALTH, 2019, 14 (02) : 227 - 240
  • [2] Economic burden of diabetes care: The economic burden on health systems of low and middle-income African countries
    Ahmed, Almoutaz Aljkhier
    Almulla, Nada Najib
    [J]. WORLD FAMILY MEDICINE, 2020, 18 (12): : 248 - 257
  • [3] Infrastructure and Economic Growth: Evidence from Lower Middle-Income Countries
    Rimsha Irshad
    Naghmana Mehr-un-Nisa
    [J]. Journal of the Knowledge Economy, 2023, 14 : 161 - 179
  • [4] Infrastructure and Economic Growth: Evidence from Lower Middle-Income Countries
    Irshad, Rimsha
    Mehr-un-Nisa
    Ghafoor, Naghmana
    [J]. JOURNAL OF THE KNOWLEDGE ECONOMY, 2023, 14 (01) : 161 - 179
  • [5] Industrial pollution and human health: evidence from middle-income countries
    Hafiz Muhammad Abubakar Siddique
    Adiqa K. Kiani
    [J]. Environmental Science and Pollution Research, 2020, 27 : 12439 - 12448
  • [6] Industrial pollution and human health: evidence from middle-income countries
    Siddique, Hafiz Muhammad Abubakar
    Kiani, Adiqa K.
    [J]. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2020, 27 (11) : 12439 - 12448
  • [7] A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries
    Butt, Muhammad Daoud
    Ong, Siew Chin
    Rafiq, Azra
    Kalam, Muhammad Nasir
    Sajjad, Ahsan
    Abdullah, Muhammad
    Malik, Tooba
    Yaseen, Fatima
    Babar, Zaheer-Ud-Din
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [8] Gendered health systems: evidence from low- and middle-income countries
    Morgan, Rosemary
    Ayiasi, Richard Mangwi
    Barman, Debjani
    Buzuzi, Stephen
    Ssemugabo, Charles
    Ezumah, Nkoli
    George, Asha S.
    Hawkins, Kate
    Hao, Xiaoning
    King, Rebecca
    Liu, Tianyang
    Molyneux, Sassy
    Muraya, Kelly W.
    Musoke, David
    Nyamhanga, Tumaini
    Ros, Bandeth
    Tani, Kassimu
    Theobald, Sally
    Vong, Sreytouch
    Waldman, Linda
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2018, 16
  • [9] Gendered health systems: evidence from low- and middle-income countries
    Rosemary Morgan
    Richard Mangwi Ayiasi
    Debjani Barman
    Stephen Buzuzi
    Charles Ssemugabo
    Nkoli Ezumah
    Asha S. George
    Kate Hawkins
    Xiaoning Hao
    Rebecca King
    Tianyang Liu
    Sassy Molyneux
    Kelly W. Muraya
    David Musoke
    Tumaini Nyamhanga
    Bandeth Ros
    Kassimu Tani
    Sally Theobald
    Sreytouch Vong
    Linda Waldman
    [J]. Health Research Policy and Systems, 16
  • [10] Who pays more for health services in middle-income countries:: lessons from Mexico
    Arredondo, A
    Nájera, P
    [J]. PUBLIC HEALTH, 2005, 119 (02) : 150 - 152